jefferies michael yee explains why he is bullish on biotech in 2022
Published 2 years ago • 8K plays • Length 5:00
Download video MP4
Download video MP3
Similar videos
-
3:33
jefferies' michael yee still likes amgen in the biotech sector
-
4:18
biotech stocks have been overlooked for the past year and a half, says jefferies' michael yee
-
2:46
biotech will face challenges this year, says jefferies' michael yee
-
2:57
jefferies' michael yee explains his top biotech picks: vrtx, fate, zlab
-
4:30
ge vernova: here's why jefferies' julien dumoulin-smith is bullish on the stock
-
3:20
jefferies' michael yee expects big opportunities for a.i. in the biotech sector
-
5:58
we see big pharma going after smaller biotechs in 2024, says jefferies' michael yee
-
4:43
m&a madness: top analyst on how biotech could rebound in 2022
-
29:19
how will china's stimulus package drive economic growth?
-
23:17
moderna co-founder and flagship pioneering ceo on the future of biotech | wsj news
-
12:37
how we built a $1.8 billion eyewear brand called warby parker
-
2:29
you can start to dip your toes into biotech here, says jefferies' yee
-
3:46
jefferies' michael yee on biogen as fda could be on the verge of approving alzheimer's drug
-
4:09
biotech remains a strong opportunity for 2021: jefferies' michael yee
-
5:52
biotech boom ahead in 2024, top jefferies analyst predicts on heels of bristol meyers-karuna deal
-
2:31
we still think there's more room for biotech to go higher, says jefferies' yee
-
2:36
the biggest wave of covid injections are behind us, says jefferies' michael yee
-
3:36
still a lot of uncertainty in moderna stock: jefferies' michael yee
-
3:34
pharma could see a wave of m&a activity in 2024, says jefferies' michael yee
-
4:31
jefferies' michael yee expects amgen's horizon therapeutics deal will go through despite ftc block
-
3:23
josh brown on biotech: i really don't think there will be any activity on drug prices next year
-
3:14
jefferies explains its bullish call on softbank
Clip.africa.com - Privacy-policy